---
title: Biomay AG vs eXmoor Pharma
slug_a: biomay
slug_b: exmoorpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/biomay/exmoorpharma
generated_by: BioBM Editorial AI
---

# Biomay AG vs eXmoor Pharma

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Biomay AG (biomay) is listed for cdmo. GMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

eXmoor Pharma (exmoorpharma) is listed for cdmo. Integrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.

Services: 9. Modalities: 3. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.